PNLIP and obesity due to melanocortin 4 receptor deficiency: The mechanisms exploited by marketed anti-obesity medicines are appetite suppression by increasing norepinephrine, dopamine, and serotonin in the synaptic clefts, pancreatic lipase, and amylase inhibition, and gastric emptying slowing.